In peripheral blood, NKp46, NKG2D, and TIGIT expression were significantly upregulated in tumor-bearing mice, while high doses of aconite treatment downregulated the expression of all three receptors (Figure 6). The gene discussed is NCR1; the disease is neoplasm.